Andy joined C4 Therapeutics in the role of Chief Scientific Officer in January 2016 and also assumed the position of President and Chief Executive Officer in May 2018. Prior to joining C4 Therapeutics, Andy was Senior Director, Center for Development of Therapeutics at Broad Institute of MIT and Harvard, where he led overall therapeutic efforts and provided strategic leadership for a number of major partnerships. Previously, he was a Full Professor of Chemistry at Yale University and a Full Professor of Chemistry and Biochemistry at the University of Colorado. His research and accomplishments have been recognized by a number of awards including the ACS Cope Scholar Award. Andy holds a Ph.D. in Biochemistry and Chemistry from the University of Canterbury.